Calling on the Scottish Parliament to urge the Scottish Government to enable access, via the NHS, to Evusheld prophylactic treatment for people who have zero or weak response to the COVID-19 vaccines.
Petitioner: Alex Marshal
Status: Closed
Date published: 12 July 2022
Click here for the full petition
SPICe Briefing (167.6KB, pdf) (168KB, pdf) posted 04 October 2022
9 November 2022: The Committee agreed to write to the COVID-19 Therapeutics Clinical Review Panel, Blood Cancer UK, Immunodeficiency UK, Kidney Research UK, the Scottish Medical Council and the Medicines and Healthcare products Regulatory Agency. It also agreed to invite the petitioner and/or the patient campaign group, Evusheld for the UK, to give evidence at a future meeting.
Official Report of Meeting 9 November 2022
08 February 2023: The Committee took evidence from Mark Oakley and Nicola Brigden, Evusheld for the UK. The Committee agreed to consider the evidence heard at a future meeting.
Official Report of Meeting 08 February 2023
19 April 2023: The Committee agreed to close the petition under Rule 15.7 of Standing Orders.
Official Report of Meeting 19 April 2023
PE1950/A: Chief Pharmaceutical Officer submission of 9 August 2022 (100.1KB, pdf) (100KB, pdf) posted 10 August 2022
PE1950/B: Blanche Hampton submission of 14 October 2022 (113.4KB, pdf) (113KB, pdf) posted 28 October 2022
PE1950/C: Scottish Medicines Consortium submission of 9 December 2022 (95.9KB, pdf) (96KB, pdf) posted 16 December 2022
PE1950/D: Immunodeficiency UK submission of 29 November 2022 (187.8KB, pdf) (188KB, pdf) posted 19 December 2022
PE1950/E: Blood Cancer UK submission of 16 December 2022 (146.3KB, pdf) (146KB, pdf) posted 19 December 2022
PE1950/F: Kidney Research UK submission of 5 January 2023 (139KB, pdf) (139KB, pdf) posted 10 January 2023
PE1950/G: Petitioner submission of 31 January 2023 (43.1KB, pdf) (43KB, pdf) posted 02 February 2023